7-Hydroxymitragynine
| Clinical data | |
|---|---|
| Other names | 7-OH; 7α-Hydroxy-7H-mitragynine; 9-Methoxycorynantheidine hydroxyindolenine | 
| Routes of administration | By mouth; inhalation | 
| Drug class | Opioid | 
| ATC code | 
 | 
| Legal status | |
| Legal status | 
 | 
| Pharmacokinetic data | |
| Metabolites | Mitragynine pseudoindoxyl | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C23H30N2O5 | 
| Molar mass | 414.502 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
7-Hydroxymitragynine (7-OH-MIT) is a terpenoid indole alkaloid present in the plant Mitragyna speciosa, commonly known as kratom. It was first described in 1994. In humans, it is produced as an active metabolite of mitragynine via hepatic oxidation. 7-OH-MIT exhibits greater binding affinity to μ-opioid receptors (MOR) than mitragynine.